PolyPeptide is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and
oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech,
it contributes to the health of millions of patients across the world. PolyPeptide offers products and services from
pre-clinical through to commercial stages, including generics.
December 3rd & 4th, 2024
December 11th& 12th 2024